Literature DB >> 30012823

Prognostic Value of Serial Echocardiography in Hypoplastic Left Heart Syndrome.

Jae Sung Son1, Adam James2, Chun-Po Steve Fan2, Luc Mertens2, Brian W McCrindle2, Cedric Manlhiot2, Mark K Friedberg3.   

Abstract

BACKGROUND: Hypoplastic left heart syndrome (HLHS) carries a high mortality. The prognostic value of echocardiographic variables at presentation and the importance of serial data are poorly explored. METHODS AND
RESULTS: We retrospectively analyzed longitudinal clinical and echocardiographic parameters of children with hypoplastic left heart syndrome. The primary outcome was time to death or transplant after stage-1 surgery, right censored at stage 3 surgery, accounting for sequential surgical procedures. Univariable and multivariable analysis identified risk factors for transplant or mortality. Time-dependent trends in echo parameters stratified by patient survival were explored using nonparametric methods. In total 67 children with hypoplastic left heart syndrome were included. The 10-week, 20-week, and 1-year survival proportions were 77.6% (66-86), 68.7% (56-78), and 54.1% (41-65), respectively. At presentation, multivariable analysis identified a thicker interventricular septum (hazard ratio [HR], 1.64; P=0.007) to be associated with increased risk for transplant/death, whereas higher tricuspid valve annular planar systolic excursion z score (HR, 0.61; P=0.003) was associated with reduced risk of mortality/transplant. After stage-1, higher body surface area-indexed right ventricular end-systolic area (HR, 1.52; P=0.02), lower fractional area change (HR, 1.18; P=0.01), and qualitatively decreased right ventricular function (HR, 2.55; P=0.08) were associated with increased risk of transplant-free mortality, censored at stage 3. Higher body surface area-indexed right ventricular end-diastolic area (HR, 0.76; P=0.04) and better tricuspid valve annular planar systolic excursion z score (HR, 0.49; P=0.01) were associated with lower mortality/transplant. During follow-up, right ventricular dilation, dysfunction, and tricuspid regurgitation improved in transplant-free survivors and worsened in those transplanted or who died.
CONCLUSIONS: Conventional echocardiographic parameters at presentation and during follow-up are potential markers for transplant-free survival in children with hypoplastic left heart syndrome.
© 2018 American Heart Association, Inc.

Entities:  

Keywords:  death; echocardiography; hypoplastic left heart syndrome; risk factors; tricuspid valve

Mesh:

Year:  2018        PMID: 30012823     DOI: 10.1161/CIRCIMAGING.117.006983

Source DB:  PubMed          Journal:  Circ Cardiovasc Imaging        ISSN: 1941-9651            Impact factor:   7.792


  9 in total

1.  Longitudinal Assessment of Right Ventricular Function in Hypoplastic Left Heart Syndrome.

Authors:  Sowmya Balasubramanian; Shea N Smith; Parthasarathy Srinivasan; Theresa A Tacy; Frank L Hanley; Sharon Chen; Gail E Wright; Lynn F Peng; Rajesh Punn
Journal:  Pediatr Cardiol       Date:  2021-05-13       Impact factor: 1.655

2.  Spinal anesthesia for open gastrostomy in an infant after stage I Norwood for hypoplastic left heart.

Authors:  Michael A Acquaviva; Doris M Hardacker; Senthil Packiasabapathy; Robert C Burns
Journal:  Ann Card Anaesth       Date:  2022 Apr-Jun

3.  Association Between Digoxin Use and Cardiac Function in Infants With Single-Ventricle Congenital Heart Disease During the Interstage Period.

Authors:  Karan R Kumar; Antonina Flair; Elizabeth J Thompson; Kanecia O Zimmerman; Nicholas D Andersen; Kevin D Hill; Christoph P Hornik
Journal:  Pediatr Crit Care Med       Date:  2022-04-11       Impact factor: 3.971

4.  Prognostic Value of Serial Echocardiography in Hypoplastic Left Heart Syndrome: Smaller Hearts, Better Results.

Authors:  Laura Mercer-Rosa; David J Goldberg
Journal:  Circ Cardiovasc Imaging       Date:  2018-07       Impact factor: 7.792

5.  Negative Impact of the Left Ventricular Remnant Morphology on Systemic Right Ventricular Myocardial Deformation in Hypoplastic Left Heart Syndrome.

Authors:  Alan P Wang; Angela M Kelle; Meredith Hyun; Chelsea L Reece; Phillip M Young; Patrick W O'Leary; M Yasir Qureshi
Journal:  Pediatr Cardiol       Date:  2020-10-26       Impact factor: 1.655

Review 6.  The role of regenerative therapy in the treatment of right ventricular failure: a literature review.

Authors:  Christoph Haller; Mark K Friedberg; Michael A Laflamme
Journal:  Stem Cell Res Ther       Date:  2020-11-25       Impact factor: 6.832

7.  Association of Digoxin With Preserved Echocardiographic Indices in the Interstage Period: A Possible Mechanism to Explain Improved Survival?

Authors:  Maria Batsis; Lazaros Kochilas; Alvin J Chin; Michael Kelleman; Eric Ferguson; Matthew E Oster
Journal:  J Am Heart Assoc       Date:  2021-12-02       Impact factor: 6.106

8.  Impact of Left Ventricular Morphology on Adverse Outcomes Following Stage 1 Palliation for Hypoplastic Left Heart Syndrome: 20 Years of National Data From Sweden.

Authors:  Katrin Fricke; Mats Mellander; Katarina Hanséus; Phan-Kiet Tran; Mats Synnergren; Jens Johansson Ramgren; Annika Rydberg; Jan Sunnegårdh; Magnus Dalén; Gunnar Sjöberg; Constance G Weismann; Petru Liuba
Journal:  J Am Heart Assoc       Date:  2022-03-29       Impact factor: 6.106

9.  Evaluation of Right Ventricular Function and Myocardial Microstructure in Fetal Hypoplastic Left Heart Syndrome.

Authors:  Jing Ma; Yaping Yuan; Li Zhang; Shizhen Chen; Haiyan Cao; Liu Hong; Juanjuan Liu; Xiaoyan Song; Jiawei Shi; Yi Zhang; Li Cui; Xin Zhou; Mingxing Xie
Journal:  J Clin Med       Date:  2022-07-30       Impact factor: 4.964

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.